Leading the new trend of peptide health technology | Taiai Peptide Group shines at the 33rd China (Chengdu) Community Health Forum and Business Expo

news

https://www.taiaitaibiology.com/

On October 23, 2025, the 33rd China (Chengdu) Community Health Forum and Business Expo grandly opened in Chengdu. Ms. Wu Xia, Chairman of Taiaipeptide Group, led a team to participate in the expo and discussed health with numerous experts, scholars, and peers.

https://www.taiaitaibiology.com/products/

https://www.taiaitaibiology.com/products/

https://www.taiaitaibiology.com/products/

This year’s expo, themed “Technology Leads, Healthy Communities,” focused on the latest achievements in the healthcare industry and innovative community service models. During the exhibition, Tai’ai Peptide Group showcased a wide range of products developed using its core small-molecule active peptide technology, offering partners a comprehensive health experience leveraging peptide technology. Its booth, with its professional scientific presentations and interactive experiences, attracted numerous visitors for consultation and partnership discussions.

https://www.taiaitaibiology.com/products/

This year’s expo, themed “Technology Leads, Healthy Communities,” focused on the latest achievements in the healthcare industry and innovative community service models. During the exhibition, Tai’ai Peptide Group showcased a wide range of products developed using its core small-molecule active peptide technology, offering partners a comprehensive health experience leveraging peptide technology. Its booth, with its professional scientific presentations and interactive experiences, attracted numerous visitors for consultation and partnership discussions.

 

https://www.taiaitaibiology.com/products/

Inheritance and innovation, standards lead digital empowerment.

https://www.taiaitaibiology.com/products/

TaiAi Peptide Group participated in this Chengdu event with the goal of bringing safer and more effective peptide health solutions to families and communities. Going forward, the Group will continue to uphold its original aspiration of “technology for the people,” increase R&D investment, promote the translation and popularization of active peptide research results, and contribute to the implementation of the “Healthy China” strategy and the improvement of national health standards.


Post time: Oct-27-2025